Dr. Josef T. Prchal, MD

Dr. Prchal practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Prchal's NPI, 1427008341, was assigned on May 11, 2006. Dr. Prchal holds Utah license 6126495-1205.

Dr. Prchal's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Prchal's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Prchal is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Prchal to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Prchal practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Prchal's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dmand AI has Dr. Prchal's licenses on file in 2 states: Utah and Texas.

CMS data shows 232 Medicare services from Dr. Prchal across 3 procedure codes in 2024, for 55 Medicare patients. Medicare paid $13,053 for them.

CMS counts 55 Medicare patients who saw Dr. Prchal in 2024. The largest group is 65 to 74, with 29 patients. 67% of them have high blood pressure, and 44% have high cholesterol. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Prchal's median patient age at 72, with 49% women.

In 2024, Dr. Prchal wrote 533 Medicare Part D claims for 63 patients. CMS names the drug for 447 of them, across 9 drugs with 11 or more claims each, at $4,328,462 in total drug cost. In 2023, CMS named 372 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Prchal for performance year 2024, reported as part of a group. Dr. Prchal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Prchal as offering telehealth.

Dmand AI links 150 papers to Dr. Prchal, published from 2010 to 2025. 2021 was the busiest year, with 13. The most frequent topics are Janus Kinase 2, Polycythemia and Polycythemia Vera. Dr. Prchal has published most often in Blood Cells Mol Dis. Dr. Prchal's most frequent co-authors are Victor R. Gordeuk, MD, Tsewang Tashi, MD and Ruben Anthony Mesa, MD.

Dmand AI links Dr. Prchal to 7 clinical trials, 2 of them phase 2 studies. Conditions studied include Thrombocythemia, Essential, Thrombocytosis and Myeloproliferative Disorders. John Mascarenhas sponsors the most, 3. Open Payments lists research payments to Dr. Prchal that name 2 trials.

CMS Open Payments shows 63 general payments to Dr. Prchal from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 36% of the total. PharmaEssentia USA Corporation paid the most, $21,072. It also lists 2 research payments totaling $480 in 2016, naming 2 clinical trials.